7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Matinas BioPharma Holdings, Inc
(NYSE MKT:MTNB) 

MTNB stock logo

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nano-crystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crysta...

Founded: 2013
Full Time Employees: 21
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Matinas BioPharma Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 028.4856.9685.45113.93142.41170.89199.37
Matinas BioPharma Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.09-0.08-0.06-0.05-0.04-0.03-0.010
Matinas BioPharma Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.09-0.08-0.07-0.05-0.04-0.03-0.010
Matinas BioPharma Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.030.050.080.10.130.150.18
Matinas BioPharma P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 022.3744.7367.189.46111.83134.19156.56
Matinas BioPharma (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -9.49-8.14-6.78-5.42-4.07-2.71-1.360
Matinas BioPharma P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.611.221.832.443.053.664.27
No extra charts and metrics for this ticker.